How Spanish biobanks have adapted the informed consent process during the Covid-19 pandemic

dc.contributor.author	Enguer-Gosálbez, Pablo
dc.contributor.author	Fons-Martínez, Jaime
dc.contributor.author	Martínez-Santamaría, Jacobo
dc.contributor.author	Torres-Redondo, Ana María
dc.contributor.author	Villena-Portella, Cristina
dc.contributor.author	García-Robles, Aurora
dc.contributor.author	Díez-Domingo, Javier
dc.date.accessioned	2021-12-20T06:55:10Z
dc.date.available	2021-12-20T06:55:10Z
dc.identifier.uri	http://hdl.handle.net/11201/156469
dc.description.abstract	[eng] Due to the situation caused by the Covid-19 pandemic, biobanks have adapted, among other processes, the obtaining of informed consents (IC). This paper details the most relevant elements of the applicable regulations, describes the adaptations done by some of the biobanks of the Spanish Biobank Network to manage the IC process, which have been approved by their Ethics Committees, and draws some conclusions from the results obtained from the survey carried out on these biobanks.
dc.format	application/pdf
dc.relation.isformatof	https://teseo.unitn.it/biolaw/article/view/1701
dc.relation.ispartof	Rivista di BioDiritto, 2021, num. 2, p. 121-138
dc.rights	, 2021
dc.subject.classification	57 - Biologia
dc.subject.other	57 - Biological sciences in general
dc.title	How Spanish biobanks have adapted the informed consent process during the Covid-19 pandemic
dc.type	info:eu-repo/semantics/article
dc.date.updated	2021-12-20T06:55:11Z
dc.rights.accessRights	info:eu-repo/semantics/openAccess